Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BRD7 encodes a protein which is a member of the bromodomain-containing protein family. Additionally we are shipping BRD7 Kits (9) and BRD7 Proteins (6) and many more products for this protein.
Showing 10 out of 53 products:
Mouse (Murine) Polyclonal BRD7 Primary Antibody for WB - ABIN657374
Burrows, Smogorzewska, Elledge: Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. in Proceedings of the National Academy of Sciences of the United States of America 2010
Show all 4 references for ABIN657374
Human Polyclonal BRD7 Primary Antibody for WB - ABIN2780896
Zhou, Tan, Hershenson: Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells. in Respiratory physiology & neurobiology 2004
Show all 2 references for ABIN2780896
constructed a regulating network of BRD7 downstream genes, and this network suggests multiple feedback regulations of the pathways. Furthermore, we validated BIRC2 (show BIRC2 Antibodies), BIRC3 (show BIRC3 Antibodies), TXN2 (show TXN2 Antibodies), and NOTCH1 (show NOTCH1 Antibodies) genes as direct, functional BRD7 targets
Propose that the balance between BRD7 function and Ras/Raf (show RAF1 Antibodies)/MEK (show MAP2K1 Antibodies)/ERK (show EPHB2 Antibodies) activity is important for determining the outcomes of HCV infection and HCC (show FAM126A Antibodies) development.
Ectopic expression of BRD7 could significantly inhibit miR (show MLXIP Antibodies)-300-promoted proliferation, invasion and epithelial-mesenchymal transition in osteosarcoma.
BRD7 promoter hypermethylation is an indicator of well differentiated oral squamous cell carcinomas.
Data indicate that bromodomain-containing protein 7 (BRD7) was a direct target of microRNA-410 (miR (show MLXIP Antibodies)-410).
lower BRD7 expression is an indicator for poor prognosis in patients with osteosarcoma.
These results suggested that BRD7 acts as a tumor suppressor in epithelial ovarian cancers
Disturbing miR (show MLXIP Antibodies)-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4 (show LRRC4 Antibodies).
BRD7-mediated translocation of a subfraction (but not all) of the p85 protein to the nucleus could enhance PI3K (show PIK3CA Antibodies) signaling.
No evidence for breast cancer susceptibility is associated with variants of BRD7.
Results link BRD7 to medial prefrontal cortex synaptic plasticity regulation; knockout leads to impaired cognitive behavior accompanied by reduced synaptic related proteins expression and dendritic spines or branching in the medial prefrontal cortex
BRD7 interacts with the regulatory subunits of phosphatidylinositol 3-kinase (PI3K) and increases the nuclear translocation of both p85alpha and p85beta and the spliced form of XBP1 (show XBP1 Antibodies) (XBP1s).
TRIM24 (show TRIM24 Antibodies) regulates AR-mediated transcription in collaboration with TIP60 (show KAT5 Antibodies) and BRD7.
BRD7 is a novel PBAF-specific SWI (show SMARCA1 Antibodies)/SNF (show SNRPA Antibodies) subunit that is required for target gene activation and repression in embryonic stem cells
This gene encodes a protein which is a member of the bromodomain-containing protein family. The product of this gene has been identified as a component of one form of the SWI/SNF chromatin remodeling complex, and as a protein which interacts with p53 and is required for p53-dependent oncogene-induced senescence which prevents tumor growth. Pseudogenes have been described on chromosomes 2, 3, 6, 13 and 14. Alternative splicing results in multiple transcript variants.
bromodomain containing 7
, nuclear transcriptor-like protein
, bromodomain-containing protein 7-like
, bromodomain-containing protein 7
, 75 kDa bromodomain protein
, protein CELTIX-1
, bromodomain protein 75 kDa
, bromodomain-containing 7
, protein tyrosine phosphatase, non-receptor type 13 interacting protein